Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1161

Oct 21, 2021

Michigan cat becomes first pet in state to test positive for virus that causes COVID-19

Posted by in category: biotech/medical

Ingham County cat tested positive for virus that causes COVID-19. Its owners were confirmed to have COVID-19 about a week before the cat became ill.

Oct 21, 2021

Cincinnati Zoo vaccinates 80 animals against Covid-19

Posted by in category: biotech/medical

The zoo said it has been vaccinating big cats, great apes, red pandas, goats, giraffes, river otters, skunks, bearcats and some domestic dogs and cats.

Oct 21, 2021

FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations

Posted by in category: biotech/medical

FDA amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for the use of a single booster dose, to be administered at least six months after completion of the primary series with the Pfizer-BioNTech COVID-19 Vaccine in certain populations.

Oct 21, 2021

Artificial Muscles Robotic Arm Full Range of Motion + Static Strength Test (V11)

Posted by in categories: biotech/medical, cyborgs, life extension, robotics/AI

We have achieved strong, fast, power-dense, high-efficiency, biomimetic, soft, safe, clean, organic and affordable robotic technology. Dumbbell weights 7 kg (15,6 lbs) 0 forearm with hand only 1 kg (2,2 lbs).

This artificial muscles robotic arm is operated by water and consumes 200W at peak. We invent and produce portable power supply and our own electro-hydraulic mini valves to have complete controllability of speed contraction and compress the whole powering system (for a full body) inside humanlike robot torso.

Continue reading “Artificial Muscles Robotic Arm Full Range of Motion + Static Strength Test (V11)” »

Oct 21, 2021

A ‘Historic Event’: First Malaria Vaccine Approved by W.H.O

Posted by in category: biotech/medical

The world has gained a new weapon in the war on malaria, among the oldest known and deadliest of infectious diseases: the first vaccine shown to help prevent the disease. By one estimate, it will save tens of thousands of children each year.

Malaria kills about half a million people each year, nearly all of them in sub-Saharan Africa — including 260,000 children under 5. The new vaccine, made by GlaxoSmithKline, rouses a child’s immune system to thwart Plasmodium falciparum, the deadliest of five malaria pathogens and the most prevalent in Africa.

The World Health Organization on Wednesday endorsed the vaccine, the first step in a process that should lead to wide distribution in poor countries. To have a malaria vaccine that is safe, moderately effective and ready for distribution is “a historic event,” said Dr. Pedro Alonso, director of the W.H.O.’s global malaria program.

Oct 21, 2021

Pig kidney attached to human found to work normally

Posted by in categories: bioengineering, biotech/medical

Surgeons have successfully attached a pig’s kidney to a human and confirmed that the body accepted the transplant in a major scientific breakthrough, The New York Times reported.

This successful operation is a promising sign as scientists work to be able to use animal organs in life-saving transplants in humans.

Scientists altered a pig gene and engineered the kidney to eliminate sugar to avoid an immune system attack. In the past, the human body would reject the transplant due to the presence of glycan, a sugar molecule in pig cells.

Oct 21, 2021

Joanna Bensz — Founder and CEO, Longevity Center And International Institute of Longevity (IIOL)

Posted by in categories: bioengineering, biotech/medical, business, life extension

Science, Technology & Protocols For Healthy Longevity And Sustainable Health — Joanna Bensz, Founder and CEO, Longevity Center & International Institute of Longevity (IIOL), joins me on Progress, Potential, And Possibilities Geopolitical Intelligence Services #Health #Wellness #Aging #Longevity #JoannaBensz #PrinceMichaelOfLiechtenstein


Joanna Bensz is Founder and CEO of Longevity Center (https://longevity-center.eu/), a boutique preventive health and longevity medical center, that focuses on scientifically and medically advanced technologies and protocols for healthy longevity and sustainable health.

Continue reading “Joanna Bensz — Founder and CEO, Longevity Center And International Institute of Longevity (IIOL)” »

Oct 21, 2021

No one knows why some people age worse than others and develop diseases-such as Alzheimer’s, fibrosis, type 2 diabetes or some types of cancer-associated with this aging process

Posted by in categories: biotech/medical, life extension, neuroscience

One explanation for this could be the degree of efficiency of each organism’s response to the damage sustained by its cells during its life, which eventually causes them to age. In relation to this, researchers at the Universitat Oberta de Catalunya (UOC) and the University of Leicester (United Kingdom) have developed a new method to remove old cells from tissues, thus slowing down the aging process.

Oct 21, 2021

Tissues, not blood, are where immune cells function

Posted by in category: biotech/medical

Early in the pandemic, my team spotted something surprising. When people were severely ill with COVID-19 and on a ventilator, the daily rinses of the plastic tubes in their windpipes contained immune cells from the airway. More surprisingly, what was in these airway samples was very different from what was found in the same patient’s blood.


COVID has shown we must study immunity in the whole body — let’s sort the logistics to acquire the right samples.

Oct 21, 2021

Researcher Predicts Anti-Aging Drug “by the Time It’s Relevant for Me”

Posted by in categories: biotech/medical, life extension

The longevity industry — startups trying to make people live longer or even forever, basically — tends to attract charlatans and scandal.

But a terrific feature story in New Statesman makes the case that a handful of ventures in the space are finally starting to hone in on some compelling ideas that might eventually provide modest or even radical life extension.

“I’m confident we’ll have an aging drug by the time it’s relevant for me,” 27-year-old Celine Halioua, a PhD dropout who now works at the anti-aging startup Loyal, who predicted that such a drug could become available “within a decade.”